News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Parth Khanna

Advertisement

Articles by Parth Khanna

The Hidden Gem: Turn AI Roleplay Data into Commercial Intelligence

ByParth Khanna
March 20th 2026

By correlating behavior data with performance outcomes, it becomes possible to predict what actually drives results.

Parth Khanna, CEO of ACTO.jpg

Clinical Evidence Key to Commercializing Life Science Products

ByParth Khanna
June 17th 2019

Pharmaceutical Executive

Companies need to find compelling ways to present facts, rather than slick but insubstantial promotions.

Advertisement

Latest Updated Articles

  • The Hidden Gem: Turn AI Roleplay Data into Commercial Intelligence
    The Hidden Gem: Turn AI Roleplay Data into Commercial Intelligence

    March 20th 2026

  • Parth Khanna, CEO of ACTO.jpg
    Clinical Evidence Key to Commercializing Life Science Products

    June 17th 2019



Advertisement
Advertisement

Trending on PharmExec

1

Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock

2

Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake

3

Quotient Therapeutics Enters Research Collaboration with Merck to Discover Drug Targets in Inflammatory Bowel Disease

4

Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines

5

Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us